The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
2 other identifiers
interventional
951
1 country
121
Brief Summary
This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2011
Shorter than P25 for phase_2
121 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2011
CompletedFirst Posted
Study publicly available on registry
September 7, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedResults Posted
Study results publicly available
November 29, 2017
CompletedMay 28, 2019
May 1, 2019
1.2 years
September 6, 2011
October 25, 2017
May 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Responder 9/12 Weeks
A Complete Spontaneous Bowel Movement (CSBM) is a Bowel Movement (BM) that occurs in the absence of laxative use within 24 hours of the BM and the patient reports a feeling of complete evacuation. A weekly responder will have 3 or more CSBMs and an increase of at least one CSBM from baseline in the same week. An overall responder is a patient who is a weekly responder for at least 9 of the 12 treatment weeks, including at least 3 of the last 4 weeks.
12-Week Treatment Period
Secondary Outcomes (4)
Change From Baseline in 12-week CSBM Weekly Frequency Rate
12-Week Treatment Period
Change From Baseline in 12-week SBM Weekly Frequency Rate
12-Week Treatment Period
Change From Baseline in Stool Consistency (BSFS) to Over Treatment Period
12-Week Treatment Period
Change From Baseline in 12-week Patient Reported Symptoms Associated With Constipation - Straining Score
12-Week Treatment Period
Study Arms (4)
plecanatide 0.3 mg
EXPERIMENTALSubjects receive plecanatide 0.3 mg for 12 consecutive weeks
plecanatide 1.0 mg
EXPERIMENTALSubjects receive plecanatide 1.0 mg for 12 consecutive weeks
plecanatide 3.0 mg
EXPERIMENTALSubjects receive plecanatide 3.0 mg for 12 consecutive weeks
Placebo
PLACEBO COMPARATORSubjects receive placebo for 12 consecutive weeks
Interventions
Subjects receive experimental study drug for 12 weeks.
Eligibility Criteria
You may qualify if:
- Male or female aged 18-75, inclusive
- Body Mass Index = 18-35 kg/m2, inclusive
- Meets modified Rome III criteria for functional chronic idiopathic constipation for at least 3 months with symptom onset for at least 6 months. Note: For this trial, patients with manual maneuvers required for \>25% of defecations will not be eligible for participation.
- Less than 3 CSBMs per week at baseline and during pretreatment
- Completed a colonoscopy in accordance with medical guidelines as appropriate, with no clinically significant findings
- Patient is willing to discontinue use of supplemental fiber, laxatives, prescription and nonprescription medications, herbal or dietary supplements intended to treat constipation during the screening, pre-treatment, treatment and 2-week post-treatment periods
- Willing to maintain a stable diet during the study.
- Patients with hemorrhoids and/or diverticulosis (NOT diverticulitis) CAN be entered into the study.
You may not qualify if:
- Loose stool (mushy) or watery (Bristol score- 6 or 7) stool in the absence of any laxative or prohibited medicine for \> 25% of BMs during the 3 months prior to screening visit OR during the 14 day treatment period
- Patient meets the Rome III criteria for Irritable Bowel Syndrome (IBS-C)
- Active peptic ulcer disease not adequately treated or not stable
- History of cathartic colon, laxative, enema abuse, or ischemic colitis.
- Fecal impaction within 3 months of screening
- Patient has had /has any: diseases or conditions associated with constipation (GI or CNS), structural abnormality of the GI tract or gastric bypass surgery, pelvic floor dysfunction, pseudo-obstruction, active infectious gastritis, diverticulitis, anal fissures or any disease or condition that can affect GI motility or defecation or can be associated with abdominal pain
- Unexplained and clinically significant "alarm symptoms" including lower GI bleeding, iron-deficiency anemia, weight loss or systemic signs of infection or colitis.
- Major surgery within 60 days of screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bausch Health Americas, Inc.lead
- Parexelcollaborator
Study Sites (121)
Coastal Clinical Research, Inc.
Mobile, Alabama, 36608, United States
East Valley Gastroenterology and Hepatology Associates, PC
Chandler, Arizona, 85224, United States
Genova Clinical Research
Tucson, Arizona, 85704, United States
Desert Sun Clinical Research, LLC
Tucson, Arizona, 85710, United States
Adobe Clinical Research, LLC
Tucson, Arizona, 85712, United States
Preferred Research Partners, Inc
Little Rock, Arkansas, 72211, United States
ACRI-Phase 1,LLC
Anaheim, California, 92801, United States
Translational Research Group, INC., d/b/a Providence Clinical Research
Burbank, California, 91505, United States
GW Research, Inc
Chula Vista, California, 91910, United States
Community Clinical Trials
Orange, California, 92868, United States
Dormir Clinical Trials, Inc
Redlands, California, 92373, United States
Inland Gastroenterology Medical Associates, Inc.
Redlands, California, 92374, United States
Superior Research LLC
Sacramento, California, 95825, United States
Medical Center for Clinical Research
San Diego, California, 92108, United States
Medical Associates Research Group, Inc.
San Diego, California, 92123, United States
Progressive Clinical Research
Vista, California, 92083, United States
Horizons Clinical Research Center, LLC
Denver, Colorado, 80220, United States
Consultants for Clinical Research of S. Florida
Boynton Beach, Florida, 33426, United States
Medical Research Unlimited, LLC
Hialeah, Florida, 33012, United States
Nature Coast Clinical Research
Inverness, Florida, 34452, United States
Health Awareness, Inc.
Jupiter, Florida, 33458, United States
Jupiter Research, Inc.
Jupiter, Florida, 33458, United States
Miami Gastroenterology Consultants, PA
Miami, Florida, 33156, United States
Advance Medical Research Service Corp
Miami, Florida, 33165, United States
Advance Medical Research Service
Miami, Florida, 33165, United States
Florida International Research Center
Miami, Florida, 33166, United States
Columbus Clinical Services, LLC
Miami, Florida, 33174, United States
South Medical Research Group, Inc
Miami, Florida, 33186, United States
Compass Research, LLC
Orlando, Florida, 32806, United States
Gold Coast Research, LLC
Plantation, Florida, 33317, United States
DMI Research
Seminole, Florida, 33777, United States
Meridien Research
Tampa, Florida, 33606, United States
Palm Beach Research Center
West Palm Beach, Florida, 33409, United States
Gastro Specialists Research Center, LLC
Decatur, Georgia, 30032, United States
Mount Vernon Clinical Research, LLC
Sandy Springs, Georgia, 30328, United States
CTL Research
Eagle, Idaho, 83616, United States
Advanced Clinical Research
Meridian, Idaho, 83642, United States
Medex Healthcare Research, Inc.
Chicago, Illinois, 60602, United States
Southwest Gastroenterology Assoc
Oak Lawn, Illinois, 60453, United States
Rockford Gastroenterology Associates, Ltd.
Rockford, Illinois, 61107, United States
Investigators Research Group, LLC
Brownsburg, Indiana, 46112, United States
MediSphere Medical Research Center, LLC
Evansville, Indiana, 47714, United States
Memorial Health System, Inc., d/b/a LaPorte Medical Group
La Porte, Indiana, 46350, United States
Memorial Health System, Inc., d/b/a Ireland Road Medical Group
South Bend, Indiana, 46614, United States
Iowa Digestive Disease Center
Clive, Iowa, 50325, United States
Heartland Research Associates, LLC
Augusta, Kansas, 67010, United States
Hutchinson Clinic, P.A
Hutchinson, Kansas, 67502, United States
Heartland Research Associates, LLC
Newton, Kansas, 67114, United States
Heartland Research Associates, LLC
Wichita, Kansas, 67205, United States
Heartland Research Associates, LLC
Wichita, Kansas, 67207, United States
Research Integrity
Owensboro, Kentucky, 42303, United States
Horizon Research Group, LLC
Baton Rouge, Louisiana, 70808, United States
Gastroenterology Associates, LLC
Baton Rouge, Louisiana, 70809, United States
Women Under Study, LLC
New Orleans, Louisiana, 70115, United States
Willis-Knighton Physician Network / Pinnacle Gastroenterology
Shreveport, Louisiana, 71103, United States
Mid-Atlantic Medical Research Centers
Hollywood, Maryland, 20636, United States
Boston Clinical Trials, Inc
Boston, Massachusetts, 02135, United States
NECCR Internal Medicine and Cardiology Associates, LLC
Fall River, Massachusetts, 02720, United States
Clinical Research Institute of Michigan, LLC
Chesterfield, Michigan, 48047, United States
Beyer Research
Kalamazoo, Michigan, 49009, United States
Remedica LLC
Rochester, Michigan, 48307, United States
American Center for Clinical Trials
Southfield, Michigan, 48034, United States
Ridgeview Research
Chaska, Minnesota, 55318, United States
The Center for Pharmaceutical Research, PC
Kansas City, Missouri, 64114, United States
Midwest Center for Clinical Research
Lee's Summit, Missouri, 64064, United States
St. Louis Center for Clinical Research
St Louis, Missouri, 63128, United States
Internal Medical Associates of Grand Island, PC
Grand Island, Nebraska, 68803, United States
Quality Clinical Research Inc.
Omaha, Nebraska, 68114, United States
Central Jersey Medical Research Center
Elizabeth, New Jersey, 07202, United States
South Jersey Gastroenterology, PA
Marlton, New Jersey, 08053, United States
Jeffrey Danzig
Ridgewood, New Jersey, 07450, United States
Albuquerque Clinical Trials, Inc
Albuquerque, New Mexico, 87102, United States
Lovelace Scientific Resources, Inc
Albuquerque, New Mexico, 87108, United States
NY Total Medical Care
Brooklyn, New York, 11215, United States
Synergy First
Brooklyn, New York, 11230, United States
Long Island Gastrointestinal Research Group LLP
Great Neck, New York, 11023, United States
Premier Medical Group of the Hudson Valley, PC
Poughkeepsie, New York, 12601, United States
North American Partners in Pain Management
Valley Stream, New York, 11580, United States
Paddu and Associates, LLP
Woodside, New York, 11377, United States
MediSpect, LLC
Boone, North Carolina, 28607, United States
Clinical and Translational Research Center Hospital
Chapel Hill, North Carolina, 27599-7600, United States
Carolina Digestive Health Associates
Charlotte, North Carolina, 28210, United States
Carolina Digestive Health Associates
Davidson, North Carolina, 28036, United States
LeBauer Research Associates, PA
Greensboro, North Carolina, 27403, United States
Medoff Medical / Vital re:Search
Greensboro, North Carolina, 27408, United States
Carolina Digestive Health Associates
Harrisburg, North Carolina, 28075, United States
Burke Primary Care
Morgantown, North Carolina, 28655, United States
Wake Research associates, LLC
Raleigh, North Carolina, 27612, United States
PMG Research of Wilmington
Wilmington, North Carolina, 28401, United States
PMG Research of Winston-Salem
Winston-Salem, North Carolina, 27103, United States
Valley Medical Research
Centerville, Ohio, 45459, United States
Hometown Urgent Care
Columbus, Ohio, 43214, United States
Hometown Urgent Care and Research
Dayton, Ohio, 45432, United States
Hometown Urgent Care
Groveport, Ohio, 43125, United States
Great Lakes Gastroenterology
Mentor, Ohio, 44060, United States
Hometown Urgent Care and Research
Springfield, Ohio, 45504, United States
Clinical Research Associates, LLC
Oklahoma City, Oklahoma, 73112, United States
Consultants in Gastroenerology
Columbia, South Carolina, 29203, United States
ClinSearch, LLC
Chattanooga, Tennessee, 37421, United States
Associates in Gastroenterology
Hermitage, Tennessee, 37076, United States
HCCA Clinical Research Solutions
Jackson, Tennessee, 38305, United States
PMG Research of Knoxville
Knoxville, Tennessee, 37912, United States
St. Thomas Medical Group
Nashville, Tennessee, 37205, United States
KRK Medical Research
Dallas, Texas, 75230, United States
Research Across America
Dallas, Texas, 75234, United States
Reasearch Across America
El Paso, Texas, 79902, United States
Gastroenterology Consultants
Houston, Texas, 77034, United States
Pioneer Research Solutions, Inc.
Houston, Texas, 77098, United States
Research Across America
Katy, Texas, 77450, United States
DCOL Center for Clinical Research
Longview, Texas, 75605, United States
Digestive Health Center
Pasadena, Texas, 77505, United States
Quality Research Inc.
San Antonio, Texas, 78209, United States
Spring Gastroenterology PA
Spring, Texas, 77386, United States
Utah Clinical Trials. LLC
Salt Lake City, Utah, 84107, United States
Jean Brown Research
Salt Lake City, Utah, 84124, United States
Advanced Clinical Research
West Jordan, Utah, 84088, United States
New River Valley Research Institute
Christiansburg, Virginia, 24073, United States
Clinical Research Partners, LLC
Henrico, Virginia, 23233, United States
Blue Ridge Medical Research / Gastroenterology Associates of Central Virginia
Lynchburg, Virginia, 24502, United States
National Clinical Research-Norfolk, Inc
Norfolk, Virginia, 23502, United States
National Clinical Research-Richmond, Inc.
Richmond, Virginia, 23294, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Patrick H. Griffin
- Organization
- Synergy Pharmaceuticals Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2011
First Posted
September 7, 2011
Study Start
October 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
May 28, 2019
Results First Posted
November 29, 2017
Record last verified: 2019-05